We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.2B
AUM Growth
+$637M
Cap. Flow
+$73.9M
Cap. Flow %
0.9%
Top 10 Hldgs %
20.74%
Holding
1,748
New
145
Increased
727
Reduced
671
Closed
102

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
VOD icon
Vodafone
VOD
+$12.3M
3
C icon
Citigroup
C
+$9.22M
4
MAG
MAG Silver
MAG
+$8.98M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.69M

Sector Composition

Rank Sector Weight
1 Technology 21.92%
2 Financials 10.53%
3 Industrials 8.25%
4 Consumer Discretionary 6.5%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIT icon
1626
Wipro
WIT
$19.5B
$55.2K ﹤0.01%
21,000
JQC icon
1627
Nuveen Credit Strategies Income Fund
JQC
$702M
$53.5K ﹤0.01%
10,147
MPT
1628
Medical Properties Trust
MPT
$2.84B
$52.7K ﹤0.01%
10,392
-5,680
-35% -$25K
DHY
1629
Credit Suisse High Yield Credit Fund
DHY
$240M
$52K ﹤0.01%
25,255
EVTL icon
1630
Vertical Aerospace
EVTL
$154M
$51.9K ﹤0.01%
+10,000
New +$55.6K
VVR icon
1631
Invesco Senior Income Trust
VVR
$456M
$47.4K ﹤0.01%
+13,697
New +$49.9K
CLVT icon
1632
Clarivate
CLVT
$1.38B
$46K ﹤0.01%
12,000
-10,000
-45% -$42K
ABEV icon
1633
Ambev
ABEV
$47.9B
$45.7K ﹤0.01%
20,487
PSEC icon
1634
Prospect Capital
PSEC
$1.08B
$43.7K ﹤0.01%
15,878
LRMR icon
1635
Larimar Therapeutics
LRMR
$377M
$32.3K ﹤0.01%
10,000
LXRX icon
1636
Lexicon Pharmaceuticals
LXRX
$1.03B
$31.7K ﹤0.01%
23,500
PLUG icon
1637
Plug Power
PLUG
$2.65B
$27.6K ﹤0.01%
11,836
ARAY icon
1638
Accuray
ARAY
$27.5M
$26.7K ﹤0.01%
16,000
TLRY icon
1639
Tilray
TLRY
$543M
$24.7K ﹤0.01%
+1,426
New +$13.6K
WRN
1640
Western Copper and Gold
WRN
$456M
$19.7K ﹤0.01%
10,000
SEED icon
1641
Origin Agritech
SEED
$11.9M
$18.1K ﹤0.01%
15,000
MLSS icon
1642
Milestone Scientific
MLSS
$33.3M
$17K ﹤0.01%
37,500
OTLK icon
1643
Outlook Therapeutics
OTLK
$187M
$13.8K ﹤0.01%
13,000
-1,700
-12% -$2.94K
ALLO icon
1644
Allogene Therapeutics
ALLO
$625M
$13K ﹤0.01%
10,500
BARK icon
1645
BARK
BARK
$77.9M
$9.55K ﹤0.01%
575
UTF.RT
1646
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
$2.56K ﹤0.01%
+32,775
New +$2.47K
ACLS icon
1647
Axcelis
ACLS
$3.44B
-6,256
Closed -$436K
ACWX icon
1648
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
-3,293
Closed -$201K
AER icon
1649
AerCap
AER
$23.4B
-19,318
Closed -$2.26M
AGCO icon
1650
AGCO
AGCO
$8.41B
-2,325
Closed -$240K

Similar funds

Oppenheimer & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Oppenheimer & Co held 1,748 positions worth $8.2B, up 8.4% from $7.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q3 2025 filing shows 145 new, 727 increased, 671 reduced and 102 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 111,989 shares worth $8.56M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q3 2025 buy was SPDR Gold MiniShares Trust: 111,989 shares worth $8.56M.
  • Oppenheimer & Co added most to AST SpaceMobile in Q3 2025, an estimated $8.33M increase.
  • Oppenheimer & Co's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Oppenheimer & Co fully exited MAG Silver in Q3 2025, selling an estimated $8.98M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $8.2B portfolio in Q3 2025.
  • Oppenheimer & Co opened 145 new positions and closed 102 in Q3 2025.
  • Oppenheimer & Co's portfolio value rose 8.4% quarter-over-quarter to $8.2B.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.